The Brink's Company (BCO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting will be held on May 8, 2025, in Dallas, Texas, with voting on nine director nominees, an advisory vote on executive compensation, and approval of KPMG LLP as the independent auditor for 2025.
2024 financial highlights include $5.0B in revenue (+3%), $912M adjusted EBITDA (+5%), $629M non-GAAP operating profit (+2%), and $400M free cash flow.
AMS/DRS revenue grew 20% to $1.2B, with 23% organic growth in these strategic areas.
The company continued to focus on organic growth, operational efficiency, and disciplined capital allocation.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine directors, an advisory resolution on executive compensation, and the selection of KPMG LLP as independent auditor.
The board recommends voting FOR all proposals.
Shareholders can vote by mail, phone, internet, or in person.
Board of directors and corporate governance
Board consists of nine nominees, 89% of whom are independent, with an average tenure of 7.9 years.
Separate CEO and Chairman roles; all standing committees are fully independent.
Board committees include Audit, Compensation, Corporate Governance, and Finance, each chaired by an independent director.
Annual board, committee, and individual evaluations are conducted, with periodic use of external facilitators.
Proxy access rights and majority vote standard for uncontested director elections are in place.
Latest events from The Brink's Company
- Annual meeting covers director elections, pay, auditor, equity plan, and ESG-linked proposals.BCO
Proxy filing20 Mar 2026 - $6.6B merger forms a global fintech leader with $200M synergies and expanded reach.BCO
M&A announcement27 Feb 2026 - $6.6B deal forms a $10B revenue fintech leader with $200M synergies and record cash flow.BCO
Q4 202526 Feb 2026 - Record Q2 revenue, margin expansion, and strong AMS/DRS growth drive positive 2024 outlook.BCO
Q2 20242 Feb 2026 - AMS/DRS growth outpaced expectations, but FX and security losses pressured Q3 profits.BCO
Q3 202416 Jan 2026 - AMS/DRS drove 12% organic growth, margin expansion, and strong cash flow in 2024.BCO
Q4 202417 Dec 2025 - Q2 2025 saw record margins, 5% organic growth, and $130M in share repurchases.BCO
Q2 202523 Nov 2025 - Q1 2025 saw 6% organic growth, margin gains, and accelerated share repurchases.BCO
Q1 202521 Nov 2025 - Q3 2025 saw record margins, 6% revenue growth, and strong AMS/DRS expansion.BCO
Q3 20256 Nov 2025